M P Girard

Summary

Country: France

Publications

  1. ncbi HIV/AIDS vaccines: a need for new concepts?
    Marc P Girard
    Paris 7 Denis Diderot University, Lyon, France
    Int Rev Immunol 27:447-71. 2008
  2. ncbi Report of the 6th meeting on the evaluation of pandemic influenza vaccines in clinical trials World Health Organization, Geneva, Switzerland, 17-18 February 2010
    Marc P Girard
    French National Academy of Medicine, 39 rue Seignemartin, 69008 Lyon, France
    Vaccine 28:6811-20. 2010
  3. ncbi Human immunodeficiency virus (HIV) immunopathogenesis and vaccine development: a review
    Marc P Girard
    University Paris 7, French National Academy of Medicine, 39 rue Seignemartin, FR 69008 Lyon, France
    Vaccine 29:6191-218. 2011
  4. ncbi [HIV/AIDS vaccines: heading for new vaccine approaches?]
    M P Girard
    Università Paris VII Denis Diderot, 39 rue Seignemartin, 69008 Lyon, France
    Bull Soc Pathol Exot 101:220-6. 2008
  5. ncbi [Development of an AIDS vaccine: status report]
    M P Girard
    L Université Paris, 7 Denis Diderot, Lyon, France
    Med Trop (Mars) 67:340-6. 2007
  6. ncbi The 2009 A (H1N1) influenza virus pandemic: A review
    Marc P Girard
    University Paris 7 Denis Diderot, 39 rue Seignemartin, 69008, Lyon, France
    Vaccine 28:4895-902. 2010
  7. ncbi A review of human vaccine research and development: malaria
    Marc P Girard
    University Paris 7, 39 rue Seignemartin, FR 69008 Lyon, France
    Vaccine 25:1567-80. 2007
  8. ncbi [Vaccines for the future]
    M P Girard
    Académie nationale de médecine, Universite Paris 7 Denis Diderot, Lyon, France
    Ann Pharm Fr 67:203-12. 2009
  9. ncbi A review of vaccine research and development: the human immunodeficiency virus (HIV)
    Marc P Girard
    University Paris 7, 39 rue Seignemartin, FR 69008 Lyon, France
    Vaccine 24:4062-81. 2006
  10. ncbi A review of vaccine research and development: human enteric infections
    Marc P Girard
    University Paris 7, UFR Biochemistry, 39 rue Seignemartin, 69008 Lyon, France
    Vaccine 24:2732-50. 2006

Detail Information

Publications20

  1. ncbi HIV/AIDS vaccines: a need for new concepts?
    Marc P Girard
    Paris 7 Denis Diderot University, Lyon, France
    Int Rev Immunol 27:447-71. 2008
    ..As a result, the research community is faced with the daunting task of identifying novel vaccine concepts and products to continue the search. This review highlights and addresses some of the scientific and practical concerns...
  2. ncbi Report of the 6th meeting on the evaluation of pandemic influenza vaccines in clinical trials World Health Organization, Geneva, Switzerland, 17-18 February 2010
    Marc P Girard
    French National Academy of Medicine, 39 rue Seignemartin, 69008 Lyon, France
    Vaccine 28:6811-20. 2010
    ..However, a second dose of vaccine was needed to boost immune responses in infants and toddlers 6 months to 3 years of age and, with some vaccines, in children aged 3-9 years...
  3. ncbi Human immunodeficiency virus (HIV) immunopathogenesis and vaccine development: a review
    Marc P Girard
    University Paris 7, French National Academy of Medicine, 39 rue Seignemartin, FR 69008 Lyon, France
    Vaccine 29:6191-218. 2011
    ..This article reviews the state of the art of HIV vaccine development and discusses the formidable scientific challenges met in this endeavor, in the context of a better understanding of the immunopathogenesis of the disease...
  4. ncbi [HIV/AIDS vaccines: heading for new vaccine approaches?]
    M P Girard
    Università Paris VII Denis Diderot, 39 rue Seignemartin, 69008 Lyon, France
    Bull Soc Pathol Exot 101:220-6. 2008
    ....
  5. ncbi [Development of an AIDS vaccine: status report]
    M P Girard
    L Université Paris, 7 Denis Diderot, Lyon, France
    Med Trop (Mars) 67:340-6. 2007
    ..These vaccines are currently being tested either singly or in various prime-boost combinations using several of these vaccines or DNA vaccines. The efficacy of these vaccination techniques in humans remains to be determined...
  6. ncbi The 2009 A (H1N1) influenza virus pandemic: A review
    Marc P Girard
    University Paris 7 Denis Diderot, 39 rue Seignemartin, 69008, Lyon, France
    Vaccine 28:4895-902. 2010
    ..The need for an increased surveillance of influenza virus circulation in swine is outlined...
  7. ncbi A review of human vaccine research and development: malaria
    Marc P Girard
    University Paris 7, 39 rue Seignemartin, FR 69008 Lyon, France
    Vaccine 25:1567-80. 2007
    ..This article attempts to summarize the state of the art of malaria vaccine development...
  8. ncbi [Vaccines for the future]
    M P Girard
    Académie nationale de médecine, Universite Paris 7 Denis Diderot, Lyon, France
    Ann Pharm Fr 67:203-12. 2009
    ..This review will focus on examples of preventive vaccines under development that target infectious diseases with a heavy global burden on public health...
  9. ncbi A review of vaccine research and development: the human immunodeficiency virus (HIV)
    Marc P Girard
    University Paris 7, 39 rue Seignemartin, FR 69008 Lyon, France
    Vaccine 24:4062-81. 2006
    ..This article reviews the state of the art in HIV vaccine development, summarizes the results obtained so far and discusses the challenges to be met in the development of the various vaccine candidates...
  10. ncbi A review of vaccine research and development: human enteric infections
    Marc P Girard
    University Paris 7, UFR Biochemistry, 39 rue Seignemartin, 69008 Lyon, France
    Vaccine 24:2732-50. 2006
    ..This article reviews the state of the art in vaccine R&D against human viral and bacterial enteric infections of public health importance...
  11. ncbi A review of vaccine research and development: human acute respiratory infections
    Marc P Girard
    University Paris 7, UFR Biochemistry, 39 rue Seignemartin, FR 69008 Lyon, France
    Vaccine 23:5708-24. 2005
    ..This article reviews the state of the art in vaccine R&D against ARIs and attempts to address these basic public health questions...
  12. ncbi A review of vaccine research and development: tuberculosis
    Marc P Girard
    University Paris 7, UFR Biochemistry, 39 rue Seignemartin, 69008 Lyon, France
    Vaccine 23:5725-31. 2005
    ..This review summarizes recent advances in tuberculosis vaccine development...
  13. ncbi Mucosal immunity and HIV/AIDS vaccines. Report of an International Workshop, 28-30 October 2007
    Marc P Girard
    Universite Paris 7 Denis Diderot, Paris, France
    Vaccine 26:3969-77. 2008
    ..This report summarizes the main concepts and conclusions that came out of the meeting...
  14. ncbi A review of vaccine research and development: meningococcal disease
    Marc P Girard
    University Paris 7, 39 rue Seignemartin, FR 69008 Lyon, France
    Vaccine 24:4692-700. 2006
    ..However, effective global prevention of meningococcal disease will not be achievable without the development of a vaccine against Group B meningitis, for which outer membrane protein vaccines are under development...
  15. ncbi Report of the third meeting on "influenza vaccines that induce broad spectrum and long-lasting immune responses", World Health Organization, Geneva, Switzerland, 3-4 December 2007
    Marc P Girard
    University Paris-Diderot, Lyon, France
    Vaccine 26:2443-50. 2008
  16. ncbi [The quest for an HIV vaccine]
    Marc P Girard
    Bull Acad Natl Med 189:831-44; discussion 844. 2005
    ..T cell-stimulating vaccines are thus unable to prevent infection but prevent or slow disease progression by controlling virus replication. Their efficacy in humans remains to be determined...
  17. ncbi Support for the RV144 HIV vaccine trial
    Robert Belshe
    Science 305:177-80; author reply 177-80. 2004
  18. ncbi Aspects of vaccine development. Introduction
    Marc P Girard
    Comp Immunol Microbiol Infect Dis 31:73-5. 2008
  19. ncbi Human vaccine research and development: an overview
    Marie Paule Kieny
    Initiative for Vaccine Research, World Health Organization, 20 Avenue Appia, , Switzerland
    Vaccine 23:5705-7. 2005
    ..Importantly, developing countries should be empowered to participate actively in the development and introduction of new vaccines according to their national priorities...
  20. ncbi More on research in France
    Marc P Girard
    Science 304:1745; author reply 1745. 2004